FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084847 [Registered on: 15/04/2025] Trial Registered Prospectively
Last Modified On: 03/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Other 
Public Title of Study   effect of Pippali and Guduchi on participants suffering from Hyperlipidemia 
Scientific Title of Study   A comparative clinical study of Pippali (Piper longum Linn) and Guduchi (Tinospora cordifolia Willd) on Medoroga WSR to Hyperlipidemia 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Preeti Solanki 
Designation  PG Scholar 
Affiliation  Govt Auto Dhanwantri Ayurved Medical College  
Address  Dept of Dravyaguna Govt Auto Dhanwantri Ayurved Medical College Mangalnath Road Ujjain

Ujjain
MADHYA PRADESH
456001
India 
Phone  9669557962  
Fax    
Email  preetifly.solanki@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shiromani Mishra 
Designation  Reader 
Affiliation  Govt Auto Dhanwantri Ayurved Medical College 
Address  Dept of Dravyaguna Govt Auto Dhanwantri Ayurved Medical College Mangalnath Road Ujjain

Ujjain
MADHYA PRADESH
456001
India 
Phone  9893158853  
Fax    
Email  shiromishra@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shiromani Mishra 
Designation  Reader 
Affiliation  Govt Auto Dhanwantri Ayurved Medical College 
Address  Dept of Dravyaguna Govt Auto Dhanwantri Ayurved Medical College Mangalnath Road Ujjain

Ujjain
MADHYA PRADESH
456001
India 
Phone  9893158853  
Fax    
Email  shiromishra@gmail.com  
 
Source of Monetary or Material Support  
Govt Auto Dhanwantri Ayurved Medical College Ujjain Madhya Pradesh India 456001  
 
Primary Sponsor  
Name  Govt Auto Dhanwantri Ayurved Medical College 
Address  Govt Auto Dhanwantri Ayurved Medical College Mangalnath Road Ujjain Madhya Pradesh India 456001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Preeti Solanki  Govt Auto Dhanwantri Ayurved Medical College   Dept of Dravyaguna Govt Auto Dhanwantri Ayurved Medical College Mangalnath Road Ujjain
Ujjain
MADHYA PRADESH 
9669557962

preetifly.solanki@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E785||Hyperlipidemia, unspecified. Ayurveda Condition: MEDOROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Guduchi, Reference: Astanghridya Sutrasthana 14/22, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -Madhu), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: pippali, Reference: Bhavprakash Nighantu Haritkyadivarga 1/57, Route: Oral, Dosage Form: Churna/ Powder, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -Madhu), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Diagnosed cases of hyperlipidemia on the basis of investigation and patients with clinical signs and symptoms of Medoroga as mentioned in Ayurveda and modern literature 
 
ExclusionCriteria 
Details  Patients suffering from type 1 Diabetes mellitus Tuberculosis Renal cirrhosis or carcinoma
Pregnant women 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in sign and symptoms of disease  Change in sign and symptoms of disease at 7th week  
 
Secondary Outcome  
Outcome  TimePoints 
assessment of changes in clinical parameter after 15 days  1st follow up at 15th day
2nd follow up at 30th day
after treatment 45th day 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   30/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is randomized interventional " A Comparative clinical study of Pippali Churna (Piper longum Linn.) and Guduchi churna (Tinospora cordifolia Willd.) on Medoroga W.S.R. to Hyperlipidemia". Patients will be selected randomly for the study and will be divided into 2 groups. Each group will contain 30 patients. For the present study patients of either sex having the age group of 20 to 65 years who will present with complains of sign and symptoms of Medoroga w.s.r. to Hyperlipidemia will be selected irrespective of their religion and occupation etc. from the OPD of Government Dhanwantri Ayurveda medical College & Hospital Ujjain M.P. 
Close